DNTH
Dianthus Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$108.10
+0.23%Margins
Gross margin
96.0%
EBITDA margin
-1549.9%
EBIT margin
—
Net margin
-1570.9%
FCF margin
-8178.0%
-2.6%
Return on equity
-2.5%
Return on assets
-18.6%
Return on invested capital
0.00x
Asset turnover
-$155.4M
Cash from operations
$16
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026